Katya Harfmann

Katya Harfmann is a pediatric dermatology researcher whose work focuses on hair-loss conditions like alopecia areata (an autoimmune condition causing patchy or complete hair loss) and vascular birthmarks such as infantile hemangiomas in children. Her recent studies include clinical trial analyses of a drug called ritlecitinib for treating alopecia areata in adolescents, as well as work on disease severity, quality of life, and treatment patterns for these skin conditions in pediatric patients.

Publication output has grown over the last decade, rising from sporadic single papers per year to a peak of four in 2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026